Handelsbanken Fonder’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,923
| Closed | -$270K | – | 1567 |
|
|
2024
Q3 | $270K | Buy |
17,923
+6,000
| +50% | +$90.4K | ﹤0.01% | 1437 |
|
|
2024
Q2 | $341K | Buy |
11,923
+2,300
| +24% | +$65.8K | ﹤0.01% | 1332 |
|
|
2024
Q1 | $281K | Hold |
9,623
| – | – | ﹤0.01% | 1408 |
|
|
2023
Q4 | $325K | Hold |
9,623
| – | – | ﹤0.01% | 1358 |
|
|
2023
Q3 | $295K | Hold |
9,623
| – | – | ﹤0.01% | 1316 |
|
|
2023
Q2 | $386K | Hold |
9,623
| – | – | ﹤0.01% | 1208 |
|
|
2023
Q1 | $393K | Hold |
9,623
| – | – | ﹤0.01% | 1130 |
|
|
2022
Q4 | $372K | Hold |
9,623
| – | – | ﹤0.01% | 1126 |
|
|
2022
Q3 | $512K | Hold |
9,623
| – | – | ﹤0.01% | 952 |
|
|
2022
Q2 | $561K | Hold |
9,623
| – | – | ﹤0.01% | 955 |
|
|
2022
Q1 | $734K | Hold |
9,623
| – | – | ﹤0.01% | 946 |
|
|
2021
Q4 | $579K | Hold |
9,623
| – | – | ﹤0.01% | 1249 |
|
|
2021
Q3 | $539K | Hold |
9,623
| – | – | ﹤0.01% | 1313 |
|
|
2021
Q2 | $584K | Buy |
9,623
+2,800
| +41% | +$170K | ﹤0.01% | 1264 |
|
|
2021
Q1 | $478K | Hold |
6,823
| – | – | ﹤0.01% | 1227 |
|
|
2020
Q4 | $408K | Hold |
6,823
| – | – | ﹤0.01% | 1264 |
|
|
2020
Q3 | $410K | Hold |
6,823
| – | – | ﹤0.01% | 1091 |
|
|
2020
Q2 | $358K | Buy |
+6,823
| New | +$358K | ﹤0.01% | 1123 |
|